The stunning breakthrough in brain-computer interfaces (BCIs) comes as Neuralink, a brain-chip startup under the leadership of Elon Musk, successfully implanted its device in a human patient. The news was revealed by Elon Musk, who noted that the patient was in a healthy condition after undergoing the procedure on Sunday. This development comes after the U.S Food and Drug Administration (FDA) granted permission for human trials last year, a vital milestone in Neuralink’s quest.
The surgery is performed with due care by a surgical robot, where a device is implanted in the brain region responsible for movement intention. The microscopic threads of the implant capture neural impulses and convert thoughts into digital activity. The name for this product is ‘Telepathy’, which reveals the futuristic nature of this technology.
While this development is met with optimism, Neuralink comes under criticism. Safety issues have emerged, although exacerbated by a fine from the U.S. Department of Transportation for improper handling of hazardous materials. Lawmakers have asked the U.S. Securities and Exchange Commission to investigate possible misrepresentation by Musk regarding Neuralink’s safety, due to reports of the adverse effects of animal trials.
This milestone is an achievement of the daring aim in helping paralysis patients use their thoughts to control digital interfaces. Even though the benefits are implied, the challenges and criticisms highlight a strong demand for efficient protection mechanisms in innovative technologies such as the brain-chip by Neuralink.
